How to buy Laboratory Corporation of America stock

Laboratory Corporation of America Holdings is a diagnostics & research business based in the US. Laboratory Corporation of America shares (LH) are listed on the NYSE and all prices are listed in US Dollars. Laboratory Corporation of America employs 65,160 staff and has a trailing 12-month revenue of around USD$14 billion.

Laboratory Corporation of America share price

Use our graph to track the performance of LH stocks over time.

Laboratory Corporation of America shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$98.02 - USD$252.45
50-day moving average	USD$231.6838
200-day moving average	USD$204.4796
Wall St. target price	USD$269.85
PE ratio	15.1899
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$15.88

Buy Laboratory Corporation of America shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Laboratory Corporation of America stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Laboratory Corporation of America Holdings by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Laboratory Corporation of America financials

Revenue TTM	USD$14 billion
Operating margin TTM	22.1%
Gross profit TTM	USD$5 billion
Return on assets TTM	10.13%
Return on equity TTM	18.35%
Profit margin	11.13%
Book value	$95.997
Market capitalisation	USD$23.5 billion

TTM: trailing 12 months

Shorting Laboratory Corporation of America shares

There are currently 1.6 million Laboratory Corporation of America shares held short by investors – that's known as Laboratory Corporation of America's "short interest". This figure is 14.6% up from 1.4 million last month.

There are a few different ways that this level of interest in shorting Laboratory Corporation of America shares can be evaluated.

Laboratory Corporation of America's "short interest ratio" (SIR)

Laboratory Corporation of America's "short interest ratio" (SIR) is the quantity of Laboratory Corporation of America shares currently shorted divided by the average quantity of Laboratory Corporation of America shares traded daily (recently around 725147.44186047). Laboratory Corporation of America's SIR currently stands at 2.15. In other words for every 100,000 Laboratory Corporation of America shares traded daily on the market, roughly 2150 shares are currently held short.

However Laboratory Corporation of America's short interest can also be evaluated against the total number of Laboratory Corporation of America shares, or, against the total number of tradable Laboratory Corporation of America shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Laboratory Corporation of America's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Laboratory Corporation of America shares in existence, roughly 20 shares are currently held short) or 0.0181% of the tradable shares (for every 100,000 tradable Laboratory Corporation of America shares, roughly 18 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Laboratory Corporation of America.

Find out more about how you can short Laboratory Corporation of America stock.

Laboratory Corporation of America's environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Laboratory Corporation of America.

When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.

Laboratory Corporation of America's total ESG risk score

Total ESG risk: 19.26

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Laboratory Corporation of America's overall score of 19.26 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Laboratory Corporation of America is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Laboratory Corporation of America's environmental score

Environmental score: 4.17/100

Laboratory Corporation of America's environmental score of 4.17 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.

Laboratory Corporation of America's social score

Social score: 11.07/100

Laboratory Corporation of America's social score of 11.07 puts it squarely in the 7th percentile of companies rated in the same sector. This could suggest that Laboratory Corporation of America is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.

Laboratory Corporation of America's governance score

Governance score: 13.02/100

Laboratory Corporation of America's governance score puts it squarely in the 7th percentile of companies rated in the same sector. That could suggest that Laboratory Corporation of America is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.

Laboratory Corporation of America's controversy score

Controversy score: 2/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. Laboratory Corporation of America scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Laboratory Corporation of America has, for the most part, managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Laboratory Corporation of America Holdings was last rated for ESG on: 2019-01-01.

Total ESG score	19.26
Total ESG percentile	14.56
Environmental score	4.17
Environmental score percentile	7
Social score	11.07
Social score percentile	7
Governance score	13.02
Governance score percentile	7
Level of controversy	2

Have Laboratory Corporation of America's shares ever split?

Laboratory Corporation of America's shares were split on a 2:1 basis on 13 May 2002. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Laboratory Corporation of America shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Laboratory Corporation of America shares which in turn could have impacted Laboratory Corporation of America's share price.

Laboratory Corporation of America share price volatility

Over the last 12 months, Laboratory Corporation of America's shares have ranged in value from as little as $98.02 up to $252.45. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Laboratory Corporation of America's is 1.0384. This would suggest that Laboratory Corporation of America's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Laboratory Corporation of America overview

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides testing services in the areas of women's health, allergy, diagnostic genetics, cardiovascular and infectious disease, endocrinology, oncology, coagulation, pharmacogenetics, toxicology, and medical drug monitoring; and esoteric testing, cancer diagnostics, and other procedures. In addition, it provides a suite of applications to enable patients, healthcare providers, health systems, accountable care organizations, and insurers with access to LCD's data and services, as well as billing for laboratory services. Further, it offers end-to-end drug development, medical device, and diagnostic development solutions from research to clinical development and commercial market access. The company primarily serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has collaborations with the Boston University, Columbia University, Duke University, Johns Hopkins University, The Mount Sinai Hospital, the University of Tennessee, Yale University, QIAGEN N.V, Ciox Health, Circuit Clinical, and Riverside Medical Group. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Frequently asked questions

• What percentage of Laboratory Corporation of America is owned by insiders or institutions?

  Currently 0.579% of Laboratory Corporation of America shares are held by insiders and 94.566% by institutions.

• How many people work for Laboratory Corporation of America?

  Latest data suggests 65,160 work at Laboratory Corporation of America.

• When does the fiscal year end for Laboratory Corporation of America?

  Laboratory Corporation of America's fiscal year ends in December.

• Where is Laboratory Corporation of America based?

  Laboratory Corporation of America's address is: 358 South Main Street, Burlington, NC, United States, 27215

• What is Laboratory Corporation of America's ISIN number?

  Laboratory Corporation of America's international securities identification number is: US50540R4092

• What is Laboratory Corporation of America's CUSIP number?

  Laboratory Corporation of America's Committee on Uniform Securities Identification Procedures number is: 50540R102